1. Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation
   Marcia L. Moss et al, 2017, Mediators of Inflammation CrossRef
2. Dysregulation and antimetastatic function of circLRIG1 modulated by miR-214-3p/LRIG1 axis in bladder carcinoma
   Shiliang Cheng et al, 2024, Biology Direct CrossRef
3. Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy
   Jinbo Chen et al, 2016, Journal of Experimental & Clinical Cancer Research CrossRef
4. Downregulation of leucine‐rich repeats and immunoglobulin‐like domains 1 by microRNA‐20a modulates gastric cancer multidrug resistance
   Lin Zhou et al, 2018, Cancer Science CrossRef
5. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression
   Yan Zhang et al, 2019, Journal of Cellular Physiology CrossRef
6. Adenovirus-mediated downregulation of the ubiquitin ligase RNF8 sensitizes bladder cancer to radiotherapy
   Mei-Jun Zhao et al, 2016, Oncotarget CrossRef
7. Identification of mitochondria-related action targets of quercetin in melanoma cells
   Qing Xi et al, 2023, Mitochondrial DNA Part B CrossRef
8. A microRNA-4516 inhibitor sensitizes chemo-resistant gastric cancer cells to chemotherapy by upregulating ING4
   Jun-bao Liu et al, 2018, RSC Advances CrossRef
9. LRIG1 Extracellular Domain: Structure and Function Analysis
   Yibin Xu et al, 2015, Journal of Molecular Biology CrossRef
10. Transcriptomics, molecular docking, and cross-resistance profiling of nobiletin in cancer cells and synergistic interaction with doxorubicin upon SOX5 transfection
    Aveen N. Adham et al, 2022, Phytomedicine CrossRef